NEW YORK (GenomeWeb) – Fluidigm reported after the close of the market Thursday that its first quarter revenues decreased 1 percent year over year due primarily to sagging instrument revenue.

For the three months ended March 31, the South San Francisco, California-based life science research tools firm logged $25.2 million in revenues compared to $25.5 million in the year-ago quarter. This included $20.5 million in product revenue and $4.8 million in service revenue.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.